MedTrace Logo

Questionnaire Study to Assess Quality of Life After Treatment of Fibroids

NCT00390494 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2008-06-30

No results posted yet for this study

Summary

The purpose of this study is to determine the change in symptoms and health-related quality of life in patients undergoing treatment for fibroids. Results from the questionnaire will be compared with results obtained from patients who do not have fibroids in order to determine a score range that differentiates these two groups.

Conditions

  • Leiomyoma

Interventions

PROCEDURE

Hysterectomy

PROCEDURE

Myomectomy

PROCEDURE

Uterine Fibroid Embolization

Sponsors & Collaborators

  • Walter Reed Army Medical Center

    collaborator FED

  • Georgetown University

    collaborator OTHER

  • The Cleveland Clinic

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • U.S. Army Medical Research and Development Command

    lead FED

Principal Investigators

  • James B Spies, MD · Georgetown University Hospital

  • LTC G. Larry Maxwell, MD · Walter Reed Army Medical Center

  • Richard Guido, MD · University of Pittsburgh

  • Linda D Bradley, MD · The Cleveland Clinic

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00390494 on ClinicalTrials.gov